Nuevos conocimientos sobre cómo se regula el ADN, el manual de instrucciones del cuerpo para la vida

Scientists at the Peter MacCallum Cancer Center have made a breakthrough in understanding how cells regulate DNA methylation, a critical mechanism that keeps ancient viral sequences in the human genome inactive. Their findings, published in Nature Genetics, reveal new insights into the regulation of the enzyme DNMT1, which plays a central role in maintaining these protective chemical tags on DNA. Human DNA serves as the blueprint for all biological functions, containing approximately 20,000 genes that account for just 2% of the total genetic material. The remaining majority of the genome consists of remnants of viruses that integrated into the human lineage millions of years ago. To prevent these viral sequences from causing harm, cells employ DNA methylation, a process that adds small chemical markers to DNA strands. These marks act as signals that suppress gene expression, effectively silencing potentially dangerous viral elements. DNMT1, a key enzyme in this regulatory system, ensures that these chemical tags remain intact. Researchers led by Dr. Jesse Balic and Professor Mark Dawson discovered that the activity of DNMT1 is more complex than previously understood. While it has long been recognized that disruptions in DNMT1 function contribute to diseases such as cancer, the exact mechanisms controlling its activity were unclear. The study aimed to clarify how DNMT1 operates within the cellular environment. Using targeted drugs to inhibit DNMT1, the researchers observed a reduction in DNA methylation levels. As a result, previously silenced viral regions became active, prompting the cell to respond as if it were under a viral threat. This triggered an internal antiviral defense mechanism, leading to programmed cell death. According to Professor Dawson, this phenomenon suggests that manipulating DNMT1 activity could offer novel strategies for targeting cancer cells specifically. The research also identified previously unknown factors that assist in maintaining DNA methylation and genomic stability. These discoveries highlight the importance of understanding the intricate balance required to preserve genome integrity. The findings may not only advance cancer therapy but also have broader applications in fields such as agriculture, where DNA methylation influences plant growth and resilience. Dr. Balic emphasized the potential impact of their work, noting that gaining deeper insight into DNMT1 regulation could open new pathways for treating a range of conditions. The study underscores the significance of basic scientific research in uncovering processes that govern health and disease. The research team’s efforts represent a step forward in unraveling the complexities of epigenetic regulation. By shedding light on how cells manage their genetic material, the study contributes to a growing body of knowledge that could shape future medical treatments and biotechnological innovations.